Kidney drug study: does dialysis change how avacopan works?
NCT ID NCT06468826
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 27 times
Summary
This study looked at how the body processes a single dose of the drug avacopan in 13 people—some with healthy kidneys and some with end-stage renal disease (ESRD) who need dialysis. Researchers measured drug levels in the blood and how much was removed by dialysis. The goal was to understand if kidney failure changes how the drug works, which helps doctors decide on proper dosing for ESRD patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE (ESRD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Floridian Clinical Research, LLC
Miami Lakes, Florida, 33016, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809-3017, United States
Conditions
Explore the condition pages connected to this study.